IL89056A - Pharmaceutical composition for enhancing mental function in humans comprising growth hormone releasing factor or somatostatin - Google Patents

Pharmaceutical composition for enhancing mental function in humans comprising growth hormone releasing factor or somatostatin

Info

Publication number
IL89056A
IL89056A IL8905689A IL8905689A IL89056A IL 89056 A IL89056 A IL 89056A IL 8905689 A IL8905689 A IL 8905689A IL 8905689 A IL8905689 A IL 8905689A IL 89056 A IL89056 A IL 89056A
Authority
IL
Israel
Prior art keywords
grf
somatostatin
pharmaceutical composition
growth hormone
releasing factor
Prior art date
Application number
IL8905689A
Other languages
English (en)
Other versions
IL89056A0 (en
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/148,667 external-priority patent/US4939124A/en
Application filed by Serono Lab filed Critical Serono Lab
Publication of IL89056A0 publication Critical patent/IL89056A0/xx
Publication of IL89056A publication Critical patent/IL89056A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL8905689A 1988-01-26 1989-01-24 Pharmaceutical composition for enhancing mental function in humans comprising growth hormone releasing factor or somatostatin IL89056A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/148,667 US4939124A (en) 1988-01-26 1988-01-26 Treatment and diagnosis of dementia
US07/206,100 US5089472A (en) 1988-01-26 1988-06-13 Use of growth hormone releasing factor for improving mental function

Publications (2)

Publication Number Publication Date
IL89056A0 IL89056A0 (en) 1989-08-15
IL89056A true IL89056A (en) 1994-07-31

Family

ID=26846051

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8905689A IL89056A (en) 1988-01-26 1989-01-24 Pharmaceutical composition for enhancing mental function in humans comprising growth hormone releasing factor or somatostatin

Country Status (15)

Country Link
US (1) US5089472A (da)
EP (1) EP0326381B1 (da)
JP (2) JP2847098B2 (da)
KR (1) KR970002484B1 (da)
CN (1) CN1055641C (da)
AT (1) ATE106745T1 (da)
AU (1) AU615714B2 (da)
CA (1) CA1341017C (da)
DE (1) DE68915793T2 (da)
DK (1) DK174866B1 (da)
FI (1) FI890389A7 (da)
IL (1) IL89056A (da)
NO (1) NO890336L (da)
RU (1) RU2024261C1 (da)
UA (1) UA19804A (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6449594A (en) * 1993-04-02 1994-10-24 Ohio University Enhancement of learning and/or memory by a human somatotropin
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
RU2176914C2 (ru) * 1995-05-30 2001-12-20 Эли Лилли Энд Компани Способ лечения нарушения познавательной функции
RU2169366C1 (ru) * 2000-05-26 2001-06-20 Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова Способ диагностики болезни альцгеймера
CA2699078A1 (en) * 2007-09-11 2009-04-09 Dorian Bevec Use of grf-1 (1-29 ) and corticotropin-releasing factor as therapeutic agents
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8318552D0 (en) * 1983-07-08 1983-08-10 Sandoz Ltd Organic compounds
US4747825A (en) * 1984-06-29 1988-05-31 Ferring Laboratories, Inc. Apparatus and methodology for pulsed administration of growth promoting agents
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
US4939124A (en) * 1988-01-26 1990-07-03 Laboratorios Serono S.A. Treatment and diagnosis of dementia

Also Published As

Publication number Publication date
NO890336L (no) 1989-07-27
AU615714B2 (en) 1991-10-10
DK31489A (da) 1989-07-27
DK174866B1 (da) 2004-01-05
KR890011572A (ko) 1989-08-21
DE68915793D1 (de) 1994-07-14
KR970002484B1 (en) 1997-03-05
DK31489D0 (da) 1989-01-25
NO890336D0 (no) 1989-01-26
FI890389A0 (fi) 1989-01-26
UA19804A (uk) 1997-12-25
EP0326381A3 (en) 1991-08-14
CA1341017C (en) 2000-06-06
ATE106745T1 (de) 1994-06-15
IL89056A0 (en) 1989-08-15
CN1036509A (zh) 1989-10-25
JPH10251167A (ja) 1998-09-22
AU2870089A (en) 1989-07-27
EP0326381A2 (en) 1989-08-02
JP2847098B2 (ja) 1999-01-13
JP2965949B2 (ja) 1999-10-18
JPH0242025A (ja) 1990-02-13
US5089472A (en) 1992-02-18
DE68915793T2 (de) 1995-03-09
CN1055641C (zh) 2000-08-23
FI890389A7 (fi) 1989-07-27
EP0326381B1 (en) 1994-06-08
RU2024261C1 (ru) 1994-12-15

Similar Documents

Publication Publication Date Title
Hubert et al. Autonomic, neuroendocrine, and subjective responses to emotion-inducing film stimuli
Sandman et al. The influence of fragments of the LPH chains on learning, memory and attention in animals and man
US6197830B1 (en) Method for achieving relief from sympathetically mediated pain
Robertson et al. The Gilles de la Tourette syndrome
Kastin et al. Behavioral and electrographic changes in rat and man after MSH
Xu et al. Hypothalamic and gastric myoelectrical responses during vection-induced nausea in healthy Chinese subjects
Burrowes et al. Research on the biologic aspects of violence
Dengerink et al. Effect of alcohol on emotional responses to stress.
Born et al. ACTH and attention in humans: a review
Leigh et al. A concise encyclopaedia of psychiatry
Conley et al. Modulating effects of a cold water stimulus on opioid effects in volunteers
AU615714B2 (en) Method of enhancing mental function
US5468726A (en) Treatment of neuropsychiatric disorders
Müller Salivary testosterone and simple reaction time parameters
Judson et al. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers
Lyvers et al. Effects of cigarette smoking and smoking deprivation on Wisconsin Card Sorting Test performance.
Childs et al. The use of cranial electrotherapy stimulation in post-traumatic amnesia: a report of two cases
Dodt et al. Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans
Sandyk et al. Multiple sclerosis: improvement of visuoperceptive functions by picoTesla range magnetic fields
Curtis et al. Neuroendocrine findings in anxiety disorders
Sandman et al. Neuropeptide influences on the central nervous system: A psychobiological perspective
Yang et al. The effect of morphine on responses of ventrolateral orbital cortex (VLO) neurons to colorectal distension in the rat
Ludolph et al. Chronic ergotamine abuse: evidence of functional impairment of long ascending spinal tracts
Freeman et al. Psychosurgery for pain
Haier Pain sensitivity, evoked potentials, and the dexamethasone suppression test in depressed patients

Legal Events

Date Code Title Description
HP Change in proprietorship
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
KB Patent renewed